Daiichi Sankyo
Overview
Daiichi Sankyo is a global pharmaceutical company headquartered in Japan, focused on the research, development, and commercialization of innovative medicines, with a primary emphasis on oncology. The company also engages in strategic investment activities, including corporate venture investments, acquisitions of biotechnology firms, and acting as a Limited Partner (LP) in external healthcare venture funds to enhance its research and development pipeline and access novel technologies.
Portfolio Companies
2
Website
daiichisankyo.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Novellia | Aug 2023 | Corporate Funding | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Daiichi Sankyo based?
Daiichi Sankyo is headquartered in Tokyo.
When was Daiichi Sankyo founded?
Founding year information for Daiichi Sankyo is not publicly available.
How many portfolio companies does Daiichi Sankyo have?
Daiichi Sankyo has 2 portfolio companies in Caplight's dataset.
What are some companies in Daiichi Sankyo's portfolio?
Portfolio companies visible on Caplight include Novellia.
What was Daiichi Sankyo's most recent investment shown here?
Daiichi Sankyo's most recent investment in this portfolio sample was in Novellia in 2023.
What sectors does Daiichi Sankyo focus on?
Daiichi Sankyo focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Daiichi Sankyo focus on?
Daiichi Sankyo typically invests at the Late stage.